From April 1, 2023 to June 30, 2023, the company has repurchased 159,920 shares, representing 1.95% for $0.58 million. With this, the company has completed the repurchase of 385,140 shares, representing 4.66% for $1.53 million under the buyback announced on August 16, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.77 USD | +0.36% | +6.95% | -12.89% |
Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.89% | 22.48M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Tranche Update on Lumos Pharma, Inc.'s Equity Buyback Plan announced on August 16, 2022.